

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.40093186 |
| 2 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.40093186 |
| 3 | * actin nucleation (GO:0045010) | 5.30996357 |
| 4 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.04571618 |
| 5 | neutrophil activation involved in immune response (GO:0002283) | 5.01972434 |
| 6 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.78463467 |
| 7 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.71917435 |
| 8 | barbed-end actin filament capping (GO:0051016) | 4.62927977 |
| 9 | positive thymic T cell selection (GO:0045059) | 4.29564111 |
| 10 | NIK/NF-kappaB signaling (GO:0038061) | 4.14969185 |
| 11 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.98595823 |
| 12 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.95706856 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.88469937 |
| 14 | apoptotic process involved in morphogenesis (GO:0060561) | 3.85293046 |
| 15 | epithelial cell fate commitment (GO:0072148) | 3.80126846 |
| 16 | modulation by virus of host process (GO:0019054) | 3.79840707 |
| 17 | neutrophil activation (GO:0042119) | 3.78091710 |
| 18 | granulocyte activation (GO:0036230) | 3.77131147 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.76829404 |
| 20 | negative regulation of cell killing (GO:0031342) | 3.76829404 |
| 21 | regulation of gamma-delta T cell activation (GO:0046643) | 3.75980976 |
| 22 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.71639115 |
| 23 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.71639115 |
| 24 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.68201179 |
| 25 | thymic T cell selection (GO:0045061) | 3.67487402 |
| 26 | leukocyte aggregation (GO:0070486) | 3.65409110 |
| 27 | macrophage activation involved in immune response (GO:0002281) | 3.61168276 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.51367592 |
| 29 | immunoglobulin mediated immune response (GO:0016064) | 3.40760101 |
| 30 | response to peptidoglycan (GO:0032494) | 3.39119746 |
| 31 | detection of bacterium (GO:0016045) | 3.31314662 |
| 32 | germinal center formation (GO:0002467) | 3.31226327 |
| 33 | negative thymic T cell selection (GO:0045060) | 3.29846794 |
| 34 | modulation by symbiont of host cellular process (GO:0044068) | 3.27763583 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.25908359 |
| 36 | response to muramyl dipeptide (GO:0032495) | 3.23314791 |
| 37 | activated T cell proliferation (GO:0050798) | 3.20863214 |
| 38 | positive regulation of B cell differentiation (GO:0045579) | 3.20848744 |
| 39 | negative T cell selection (GO:0043383) | 3.17765084 |
| 40 | detection of other organism (GO:0098543) | 3.17034139 |
| 41 | response to interleukin-15 (GO:0070672) | 3.15098460 |
| 42 | dosage compensation (GO:0007549) | 3.13436864 |
| 43 | cellular response to interleukin-15 (GO:0071350) | 3.13081230 |
| 44 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.12026869 |
| 45 | defense response to protozoan (GO:0042832) | 3.10634297 |
| 46 | positive regulation of tolerance induction (GO:0002645) | 3.10555231 |
| 47 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.08176297 |
| 48 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.08176297 |
| 49 | modulation by symbiont of host immune response (GO:0052553) | 3.08176297 |
| 50 | positive regulation by symbiont of host defense response (GO:0052509) | 3.08176297 |
| 51 | modulation by symbiont of host defense response (GO:0052031) | 3.08176297 |
| 52 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.08176297 |
| 53 | negative regulation of cell size (GO:0045792) | 3.07694814 |
| 54 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.07069137 |
| 55 | peptidyl-arginine methylation (GO:0018216) | 3.06675988 |
| 56 | peptidyl-arginine N-methylation (GO:0035246) | 3.06675988 |
| 57 | cytidine catabolic process (GO:0006216) | 3.05901289 |
| 58 | cytidine deamination (GO:0009972) | 3.05901289 |
| 59 | cytidine metabolic process (GO:0046087) | 3.05901289 |
| 60 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.03998290 |
| 61 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.03592113 |
| 62 | regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768) | 2.97408652 |
| 63 | viral transcription (GO:0019083) | 2.96435556 |
| 64 | response to protozoan (GO:0001562) | 2.96372646 |
| 65 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.96287785 |
| 66 | regulation of T cell tolerance induction (GO:0002664) | 2.95968795 |
| 67 | T cell selection (GO:0045058) | 2.95104132 |
| 68 | myeloid cell activation involved in immune response (GO:0002275) | 2.94817330 |
| 69 | positive regulation of protein homooligomerization (GO:0032464) | 2.94579089 |
| 70 | regulation of regulatory T cell differentiation (GO:0045589) | 2.93404246 |
| 71 | natural killer cell differentiation (GO:0001779) | 2.93381447 |
| 72 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.92770921 |
| 73 | negative regulation of granulocyte differentiation (GO:0030853) | 2.92704163 |
| 74 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.92334664 |
| 75 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.91167737 |
| 76 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.91117873 |
| 77 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.90983983 |
| 78 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.90594798 |
| 79 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.89912844 |
| 80 | * Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89886455 |
| 81 | respiratory burst (GO:0045730) | 2.88767520 |
| 82 | tolerance induction (GO:0002507) | 2.87217966 |
| 83 | positive T cell selection (GO:0043368) | 2.87102607 |
| 84 | apoptotic process involved in development (GO:1902742) | 2.87055562 |
| 85 | regulation of cell killing (GO:0031341) | 2.86619327 |
| 86 | negative regulation of glial cell proliferation (GO:0060253) | 2.86279024 |
| 87 | regulation of antigen processing and presentation (GO:0002577) | 2.84975176 |
| 88 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.84023137 |
| 89 | regulation of mast cell degranulation (GO:0043304) | 2.83915988 |
| 90 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.83785195 |
| 91 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.83283588 |
| 92 | positive regulation of histone deacetylation (GO:0031065) | 2.82203818 |
| 93 | positive regulation of lamellipodium organization (GO:1902745) | 2.79923557 |
| 94 | myeloid dendritic cell activation (GO:0001773) | 2.79822109 |
| 95 | positive regulation of lamellipodium assembly (GO:0010592) | 2.79715526 |
| 96 | regulation of chromatin binding (GO:0035561) | 2.78697249 |
| 97 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 2.77934620 |
| 98 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.74820587 |
| 99 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.74696631 |
| 100 | translational termination (GO:0006415) | 2.72733298 |
| 101 | regulation of B cell differentiation (GO:0045577) | 2.70564310 |
| 102 | positive regulation of cell killing (GO:0031343) | 2.70432429 |
| 103 | regulation of translational fidelity (GO:0006450) | 2.69223394 |
| 104 | ribosomal small subunit assembly (GO:0000028) | 2.69092577 |
| 105 | leukocyte degranulation (GO:0043299) | 2.68122760 |
| 106 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.67860348 |
| 107 | pentose-phosphate shunt (GO:0006098) | 2.67289512 |
| 108 | regulation of erythrocyte differentiation (GO:0045646) | 2.66323520 |
| 109 | response to type I interferon (GO:0034340) | 2.61171653 |
| 110 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.60392581 |
| 111 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.60286553 |
| 112 | negative regulation of T cell mediated immunity (GO:0002710) | 2.58602506 |
| 113 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.58405654 |
| 114 | positive regulation of protein deacetylation (GO:0090312) | 2.58251030 |
| 115 | response to laminar fluid shear stress (GO:0034616) | 2.57129301 |
| 116 | cellular response to type I interferon (GO:0071357) | 2.56867074 |
| 117 | type I interferon signaling pathway (GO:0060337) | 2.56867074 |
| 118 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.56662105 |
| 119 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.56578305 |
| 120 | Peyers patch development (GO:0048541) | 2.56578305 |
| 121 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.56121202 |
| 122 | histone H4-K12 acetylation (GO:0043983) | 2.55783752 |
| 123 | negative regulation of stress fiber assembly (GO:0051497) | 2.54506432 |
| 124 | regulation of protein heterodimerization activity (GO:0043497) | 2.53919992 |
| 125 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.53243267 |
| 126 | maternal placenta development (GO:0001893) | 2.52973162 |
| 127 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.52890333 |
| 128 | myeloid dendritic cell differentiation (GO:0043011) | 2.51547484 |
| 129 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.50941936 |
| 130 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.50823193 |
| 131 | developmental programmed cell death (GO:0010623) | 2.50381750 |
| 132 | positive regulation of interferon-alpha production (GO:0032727) | 2.49935867 |
| 133 | endothelial tube morphogenesis (GO:0061154) | 2.49903213 |
| 134 | morphogenesis of an endothelium (GO:0003159) | 2.49903213 |
| 135 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.49655320 |
| 136 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.49185581 |
| 137 | T cell costimulation (GO:0031295) | 2.48414909 |
| 138 | platelet formation (GO:0030220) | 2.47717919 |
| 139 | negative regulation of interleukin-6 production (GO:0032715) | 2.46850615 |
| 140 | positive regulation of protein oligomerization (GO:0032461) | 2.46019078 |
| 141 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.46003682 |
| 142 | lymphocyte costimulation (GO:0031294) | 2.45968569 |
| 143 | cellular response to zinc ion (GO:0071294) | 2.45713844 |
| 144 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 2.44964655 |
| 145 | translational elongation (GO:0006414) | 2.44040102 |
| 146 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43851907 |
| 147 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.43568265 |
| 148 | cellular response to virus (GO:0098586) | 2.41779394 |
| 149 | execution phase of apoptosis (GO:0097194) | 2.41544335 |
| 150 | retinoic acid receptor signaling pathway (GO:0048384) | 2.41531686 |
| 151 | regulation of granulocyte differentiation (GO:0030852) | 2.40795911 |
| 152 | negative regulation of phagocytosis (GO:0050765) | 2.40029514 |
| 153 | positive regulation of antigen processing and presentation (GO:0002579) | 2.39520278 |
| 154 | regulation of tolerance induction (GO:0002643) | 2.38590280 |
| 155 | negative regulation of innate immune response (GO:0045824) | 2.38557231 |
| 156 | T cell apoptotic process (GO:0070231) | 2.37983730 |
| 157 | negative regulation of interleukin-12 production (GO:0032695) | 2.37193054 |
| 158 | T cell migration (GO:0072678) | 2.36596503 |
| 159 | B cell receptor signaling pathway (GO:0050853) | 2.36570250 |
| 160 | regulation of monocyte differentiation (GO:0045655) | 2.36387243 |
| 161 | ncRNA 3-end processing (GO:0043628) | 2.35474110 |
| 162 | regulation of response to interferon-gamma (GO:0060330) | 2.34395159 |
| 163 | megakaryocyte development (GO:0035855) | 2.33981898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MYC_22102868_ChIP-Seq_BL_Human | 3.55814438 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.36152038 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.26379462 |
| 4 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.90769945 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.80087840 |
| 6 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.73731920 |
| 7 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54746960 |
| 8 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.42203595 |
| 9 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.29550648 |
| 10 | MAF_26560356_Chip-Seq_TH1_Human | 2.28119888 |
| 11 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.28017584 |
| 12 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.24363583 |
| 13 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.24072040 |
| 14 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20690849 |
| 15 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.19016050 |
| 16 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.11959452 |
| 17 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.07389846 |
| 18 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.06890257 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.04114549 |
| 20 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.03516949 |
| 21 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.99235763 |
| 22 | UTX_26944678_Chip-Seq_JUKART_Human | 1.98488873 |
| 23 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.98382175 |
| 24 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.93489343 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89632427 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.84166251 |
| 27 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.84143063 |
| 28 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.80054176 |
| 29 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.78964528 |
| 30 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73829420 |
| 31 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.67878653 |
| 32 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.66331500 |
| 33 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63147652 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.61873038 |
| 35 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.61769011 |
| 36 | MAF_26560356_Chip-Seq_TH2_Human | 1.61161585 |
| 37 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60391796 |
| 38 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.57943672 |
| 39 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.57607242 |
| 40 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55940560 |
| 41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.55628861 |
| 42 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.54019358 |
| 43 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.51256020 |
| 44 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.50159979 |
| 45 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.49160584 |
| 46 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.45660980 |
| 47 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45651633 |
| 48 | SPI1_23127762_ChIP-Seq_K562_Human | 1.42620754 |
| 49 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42497944 |
| 50 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.42041438 |
| 51 | MYB_26560356_Chip-Seq_TH1_Human | 1.41787732 |
| 52 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.41128134 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.41019899 |
| 54 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.39828839 |
| 55 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.39682271 |
| 56 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38687692 |
| 57 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38369626 |
| 58 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37053390 |
| 59 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.36309772 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.35566031 |
| 61 | P68_20966046_ChIP-Seq_HELA_Human | 1.34589300 |
| 62 | MYB_26560356_Chip-Seq_TH2_Human | 1.34083629 |
| 63 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.34017448 |
| 64 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.34014367 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.33791180 |
| 66 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.32170864 |
| 67 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.32061776 |
| 68 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.31597207 |
| 69 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.31046599 |
| 70 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.30720835 |
| 71 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.30293157 |
| 72 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.29729253 |
| 73 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.29231019 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.28998751 |
| 75 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.28920939 |
| 76 | SA1_27219007_Chip-Seq_Bcells_Human | 1.28324371 |
| 77 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.28307759 |
| 78 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.28044434 |
| 79 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.27944541 |
| 80 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.26595470 |
| 81 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.26404744 |
| 82 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25861968 |
| 83 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.25651067 |
| 84 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.25538710 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.25512674 |
| 86 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25066856 |
| 87 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.23566020 |
| 88 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.22754651 |
| 89 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.22498001 |
| 90 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22389222 |
| 91 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.21149403 |
| 92 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.20859656 |
| 93 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20027242 |
| 94 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.19646674 |
| 95 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.19616253 |
| 96 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.19027848 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19010212 |
| 98 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.18987140 |
| 99 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18419862 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.17636778 |
| 101 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.17202508 |
| 102 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.16823302 |
| 103 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.14865281 |
| 104 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.12600168 |
| 105 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.12161753 |
| 106 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.11989177 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.10426857 |
| 108 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.09946448 |
| 109 | KDM2B_26808549_Chip-Seq_K562_Human | 1.09540661 |
| 110 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 1.08898199 |
| 111 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.08837073 |
| 112 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.07388247 |
| 113 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07291235 |
| 114 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06376510 |
| 115 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.06194600 |
| 116 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.05913404 |
| 117 | P300_27268052_Chip-Seq_Bcells_Human | 1.05808435 |
| 118 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.05370722 |
| 119 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05084942 |
| 120 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.04793916 |
| 121 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.04691138 |
| 122 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03925683 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.03352624 |
| 124 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03264801 |
| 125 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.02528878 |
| 126 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.01839175 |
| 127 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.00601833 |
| 128 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00108449 |
| 129 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99625014 |
| 130 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99148414 |
| 131 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.97020991 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000685_abnormal_immune_system | 3.51846964 |
| 2 | MP0003724_increased_susceptibility_to | 3.40972373 |
| 3 | MP0009278_abnormal_bone_marrow | 3.23962600 |
| 4 | MP0001348_abnormal_lacrimal_gland | 3.15678241 |
| 5 | MP0003303_peritoneal_inflammation | 2.94472856 |
| 6 | MP0001835_abnormal_antigen_presentation | 2.75400413 |
| 7 | MP0003172_abnormal_lysosome_physiology | 2.65102703 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.56733720 |
| 9 | MP0003436_decreased_susceptibility_to | 2.54523890 |
| 10 | MP0009840_abnormal_foam_cell | 2.42248887 |
| 11 | MP0005058_abnormal_lysosome_morphology | 2.34592836 |
| 12 | MP0001800_abnormal_humoral_immune | 2.23368530 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 2.18907811 |
| 14 | MP0005076_abnormal_cell_differentiation | 2.15248802 |
| 15 | MP0001545_abnormal_hematopoietic_system | 2.13218749 |
| 16 | MP0005397_hematopoietic_system_phenotyp | 2.13218749 |
| 17 | MP0004510_myositis | 2.11917746 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.10930709 |
| 19 | MP0005387_immune_system_phenotype | 2.00283970 |
| 20 | MP0001790_abnormal_immune_system | 2.00283970 |
| 21 | MP0003191_abnormal_cellular_cholesterol | 1.99431695 |
| 22 | MP0003763_abnormal_thymus_physiology | 1.99288472 |
| 23 | MP0002398_abnormal_bone_marrow | 1.98484243 |
| 24 | MP0005464_abnormal_platelet_physiology | 1.94618021 |
| 25 | MP0005451_abnormal_body_composition | 1.94569827 |
| 26 | MP0002452_abnormal_antigen_presenting | 1.92336573 |
| 27 | MP0005025_abnormal_response_to | 1.90146467 |
| 28 | MP0008260_abnormal_autophagy | 1.89533428 |
| 29 | MP0001819_abnormal_immune_cell | 1.83314637 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.83130312 |
| 31 | MP0002723_abnormal_immune_serum | 1.82739340 |
| 32 | MP0006082_CNS_inflammation | 1.82657171 |
| 33 | MP0004808_abnormal_hematopoietic_stem | 1.79281170 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.78927188 |
| 35 | MP0005671_abnormal_response_to | 1.77881160 |
| 36 | MP0005000_abnormal_immune_tolerance | 1.76737155 |
| 37 | MP0002166_altered_tumor_susceptibility | 1.76013007 |
| 38 | MP0002089_abnormal_postnatal_growth/wei | 1.74800904 |
| 39 | MP0009785_altered_susceptibility_to | 1.71105406 |
| 40 | MP0002722_abnormal_immune_system | 1.70575579 |
| 41 | MP0000689_abnormal_spleen_morphology | 1.69726203 |
| 42 | MP0004947_skin_inflammation | 1.69230585 |
| 43 | MP0009764_decreased_sensitivity_to | 1.67343620 |
| 44 | MP0000703_abnormal_thymus_morphology | 1.66566380 |
| 45 | MP0010030_abnormal_orbit_morphology | 1.66496592 |
| 46 | MP0000716_abnormal_immune_system | 1.65393172 |
| 47 | MP0005174_abnormal_tail_pigmentation | 1.63317608 |
| 48 | MP0000015_abnormal_ear_pigmentation | 1.61223253 |
| 49 | MP0001873_stomach_inflammation | 1.58897023 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.55392218 |
| 51 | MP0002138_abnormal_hepatobiliary_system | 1.52665869 |
| 52 | MP0000604_amyloidosis | 1.52628633 |
| 53 | MP0002429_abnormal_blood_cell | 1.50967639 |
| 54 | MP0002419_abnormal_innate_immunity | 1.49706777 |
| 55 | MP0005310_abnormal_salivary_gland | 1.48410043 |
| 56 | MP0002405_respiratory_system_inflammati | 1.44286557 |
| 57 | MP0003806_abnormal_nucleotide_metabolis | 1.39418223 |
| 58 | MP0010155_abnormal_intestine_physiology | 1.37110071 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 1.31564107 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.28984858 |
| 61 | MP0000733_abnormal_muscle_development | 1.26192663 |
| 62 | MP0002148_abnormal_hypersensitivity_rea | 1.25279973 |
| 63 | MP0000858_altered_metastatic_potential | 1.25107627 |
| 64 | MP0003091_abnormal_cell_migration | 1.23273012 |
| 65 | MP0008961_abnormal_basal_metabolism | 1.22001100 |
| 66 | MP0000371_diluted_coat_color | 1.19880515 |
| 67 | MP0005023_abnormal_wound_healing | 1.18478790 |
| 68 | MP0010352_gastrointestinal_tract_polyps | 1.13131426 |
| 69 | MP0002132_abnormal_respiratory_system | 1.10938861 |
| 70 | MP0001958_emphysema | 1.09375264 |
| 71 | MP0002822_catalepsy | 1.09150605 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.07731481 |
| 73 | MP0003075_altered_response_to | 1.07577981 |
| 74 | MP0003329_amyloid_beta_deposits | 1.07248041 |
| 75 | MP0000490_abnormal_crypts_of | 1.03910040 |
| 76 | MP0001533_abnormal_skeleton_physiology | 1.03650940 |
| 77 | MP0003448_altered_tumor_morphology | 1.02570092 |
| 78 | MP0002933_joint_inflammation | 1.01972776 |
| 79 | MP0002019_abnormal_tumor_incidence | 0.99036246 |
| 80 | MP0010307_abnormal_tumor_latency | 0.96944140 |
| 81 | MP0003183_abnormal_peptide_metabolism | 0.95393088 |
| 82 | MP0000343_altered_response_to | 0.94729815 |
| 83 | MP0008469_abnormal_protein_level | 0.93864231 |
| 84 | MP0002006_tumorigenesis | 0.92743109 |
| 85 | MP0003111_abnormal_nucleus_morphology | 0.91907530 |
| 86 | MP0009763_increased_sensitivity_to | 0.87052443 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.85905574 |
| 88 | MP0005390_skeleton_phenotype | 0.85291487 |
| 89 | MP0009765_abnormal_xenobiotic_induced | 0.84658737 |
| 90 | MP0001986_abnormal_taste_sensitivity | 0.84501550 |
| 91 | MP0000313_abnormal_cell_death | 0.84371779 |
| 92 | MP0001663_abnormal_digestive_system | 0.82870858 |
| 93 | MP0002877_abnormal_melanocyte_morpholog | 0.80960802 |
| 94 | MP0002653_abnormal_ependyma_morphology | 0.80885217 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 0.80076521 |
| 96 | MP0006054_spinal_hemorrhage | 0.79799680 |
| 97 | MP0003866_abnormal_defecation | 0.79762080 |
| 98 | MP0003045_fibrosis | 0.77923519 |
| 99 | MP0005166_decreased_susceptibility_to | 0.76875343 |
| 100 | MP0005257_abnormal_intraocular_pressure | 0.76367889 |
| 101 | MP0003828_pulmonary_edema | 0.75771476 |
| 102 | MP0001849_ear_inflammation | 0.75346552 |
| 103 | MP0000609_abnormal_liver_physiology | 0.74580822 |
| 104 | MP0005535_abnormal_body_temperature | 0.74474531 |
| 105 | MP0003077_abnormal_cell_cycle | 0.74307985 |
| 106 | MP0004130_abnormal_muscle_cell | 0.73007163 |
| 107 | MP0003279_aneurysm | 0.72539956 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.72457652 |
| 109 | MP0002998_abnormal_bone_remodeling | 0.71944497 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.70074548 |
| 111 | MP0003795_abnormal_bone_structure | 0.69176352 |
| 112 | MP0003656_abnormal_erythrocyte_physiolo | 0.69067558 |
| 113 | MP0001851_eye_inflammation | 0.68641425 |
| 114 | MP0008004_abnormal_stomach_pH | 0.68054755 |
| 115 | MP0008770_decreased_survivor_rate | 0.67381343 |
| 116 | MP0005075_abnormal_melanosome_morpholog | 0.66379977 |
| 117 | MP0001764_abnormal_homeostasis | 0.66087504 |
| 118 | MP0005083_abnormal_biliary_tract | 0.65274904 |
| 119 | MP0008874_decreased_physiological_sensi | 0.64771464 |
| 120 | MP0000350_abnormal_cell_proliferation | 0.64004549 |
| 121 | MP0001853_heart_inflammation | 0.63783446 |
| 122 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.62892902 |
| 123 | MP0000598_abnormal_liver_morphology | 0.62483249 |
| 124 | MP0001915_intracranial_hemorrhage | 0.61601885 |
| 125 | MP0000767_abnormal_smooth_muscle | 0.61545036 |
| 126 | MP0000681_abnormal_thyroid_gland | 0.60063792 |
| 127 | MP0004381_abnormal_hair_follicle | 0.59817354 |
| 128 | MP0000920_abnormal_myelination | 0.58501935 |
| 129 | MP0001730_embryonic_growth_arrest | 0.58412823 |
| 130 | MP0002095_abnormal_skin_pigmentation | 0.58208572 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.57267663 |
| 132 | MP0000750_abnormal_muscle_regeneration | 0.54411573 |
| 133 | MP0003690_abnormal_glial_cell | 0.49520589 |
| 134 | MP0006036_abnormal_mitochondrial_physio | 0.49433354 |
| 135 | MP0005319_abnormal_enzyme/_coenzyme | 0.48173868 |
| 136 | MP0005381_digestive/alimentary_phenotyp | 0.47973208 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased IgM level (HP:0003496) | 3.88705535 |
| 2 | Stomatitis (HP:0010280) | 3.77642054 |
| 3 | Nasal polyposis (HP:0100582) | 3.68392071 |
| 4 | Encephalitis (HP:0002383) | 3.56789489 |
| 5 | Protrusio acetabuli (HP:0003179) | 3.54482559 |
| 6 | Eczematoid dermatitis (HP:0000976) | 3.45770115 |
| 7 | Abnormality of the nasal mucosa (HP:0000433) | 3.41140636 |
| 8 | Optic neuritis (HP:0100653) | 3.22819569 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 3.22819569 |
| 10 | Recurrent fungal infections (HP:0002841) | 3.18101696 |
| 11 | Cerebral aneurysm (HP:0004944) | 3.16462112 |
| 12 | Thrombocytosis (HP:0001894) | 3.15412180 |
| 13 | Petechiae (HP:0000967) | 3.12052092 |
| 14 | Chronic otitis media (HP:0000389) | 3.10622875 |
| 15 | Cellulitis (HP:0100658) | 3.09662553 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.01040141 |
| 17 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.90371290 |
| 18 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.90371290 |
| 19 | Abnormality of glycolipid metabolism (HP:0010969) | 2.90371290 |
| 20 | Hyperacusis (HP:0010780) | 2.83571505 |
| 21 | Hypertensive crisis (HP:0100735) | 2.79929442 |
| 22 | Granulocytopenia (HP:0001913) | 2.79418898 |
| 23 | Increased IgE level (HP:0003212) | 2.77970158 |
| 24 | Gastrointestinal inflammation (HP:0004386) | 2.76980491 |
| 25 | T lymphocytopenia (HP:0005403) | 2.76046856 |
| 26 | Recurrent abscess formation (HP:0002722) | 2.71107672 |
| 27 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.70907559 |
| 28 | Purpura (HP:0000979) | 2.70087617 |
| 29 | Pulmonary infiltrates (HP:0002113) | 2.68822412 |
| 30 | Abnormality of T cell number (HP:0011839) | 2.65708106 |
| 31 | Recurrent viral infections (HP:0004429) | 2.63667360 |
| 32 | Recurrent bronchitis (HP:0002837) | 2.60256851 |
| 33 | Albinism (HP:0001022) | 2.58368207 |
| 34 | Panhypogammaglobulinemia (HP:0003139) | 2.57965147 |
| 35 | Hypergammaglobulinemia (HP:0010702) | 2.57520121 |
| 36 | Increased serum ferritin (HP:0003281) | 2.56645984 |
| 37 | Severe combined immunodeficiency (HP:0004430) | 2.55789024 |
| 38 | Myositis (HP:0100614) | 2.55710239 |
| 39 | Frequent falls (HP:0002359) | 2.55272035 |
| 40 | Loss of speech (HP:0002371) | 2.55058733 |
| 41 | Abnormality of the lumbar spine (HP:0100712) | 2.53864104 |
| 42 | Recurrent bacterial skin infections (HP:0005406) | 2.53838905 |
| 43 | Premature loss of primary teeth (HP:0006323) | 2.53418490 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.52829254 |
| 45 | Hepatosplenomegaly (HP:0001433) | 2.52074505 |
| 46 | Agammaglobulinemia (HP:0004432) | 2.51920775 |
| 47 | Autoimmune hemolytic anemia (HP:0001890) | 2.49806678 |
| 48 | Disinhibition (HP:0000734) | 2.45608720 |
| 49 | Axonal loss (HP:0003447) | 2.45103117 |
| 50 | IgG deficiency (HP:0004315) | 2.43561022 |
| 51 | Inflammation of the large intestine (HP:0002037) | 2.42267471 |
| 52 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.42099856 |
| 53 | Recurrent cutaneous fungal infections (HP:0011370) | 2.42099856 |
| 54 | Heterotopia (HP:0002282) | 2.40355523 |
| 55 | Keratoconjunctivitis sicca (HP:0001097) | 2.39556497 |
| 56 | Colitis (HP:0002583) | 2.38591196 |
| 57 | Personality changes (HP:0000751) | 2.38011509 |
| 58 | Leukocytosis (HP:0001974) | 2.34922506 |
| 59 | Urticaria (HP:0001025) | 2.34637933 |
| 60 | Upper motor neuron abnormality (HP:0002127) | 2.34506789 |
| 61 | Vertebral compression fractures (HP:0002953) | 2.31880868 |
| 62 | Hand muscle atrophy (HP:0009130) | 2.29804709 |
| 63 | Chronic obstructive pulmonary disease (HP:0006510) | 2.26928216 |
| 64 | Obstructive lung disease (HP:0006536) | 2.26928216 |
| 65 | Agnosia (HP:0010524) | 2.26262812 |
| 66 | Recurrent skin infections (HP:0001581) | 2.24589905 |
| 67 | Dysostosis multiplex (HP:0000943) | 2.23639173 |
| 68 | Combined immunodeficiency (HP:0005387) | 2.21608902 |
| 69 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21075927 |
| 70 | Keratoconjunctivitis (HP:0001096) | 2.18798504 |
| 71 | Progressive external ophthalmoplegia (HP:0000590) | 2.18120261 |
| 72 | Meningitis (HP:0001287) | 2.17395371 |
| 73 | Eosinophilia (HP:0001880) | 2.15630031 |
| 74 | Porencephaly (HP:0002132) | 2.14929059 |
| 75 | Upper limb amyotrophy (HP:0009129) | 2.14590410 |
| 76 | Distal upper limb amyotrophy (HP:0007149) | 2.14590410 |
| 77 | Autoimmune thrombocytopenia (HP:0001973) | 2.13253603 |
| 78 | Verrucae (HP:0200043) | 2.11559497 |
| 79 | Papilloma (HP:0012740) | 2.11559497 |
| 80 | Abnormality of iron homeostasis (HP:0011031) | 2.11323394 |
| 81 | Abnormality of eosinophils (HP:0001879) | 2.11195912 |
| 82 | Hypochromic anemia (HP:0001931) | 2.08257891 |
| 83 | Episodic fever (HP:0001954) | 2.08175073 |
| 84 | Lymphopenia (HP:0001888) | 2.07277385 |
| 85 | Asymmetric septal hypertrophy (HP:0001670) | 2.06986445 |
| 86 | Abnormality of T cell physiology (HP:0011840) | 2.06699990 |
| 87 | Reticulocytosis (HP:0001923) | 2.05989475 |
| 88 | Long toe (HP:0010511) | 2.03702157 |
| 89 | Aneurysm (HP:0002617) | 2.02227412 |
| 90 | Bowing of the arm (HP:0006488) | 2.00392942 |
| 91 | Bowed forearm bones (HP:0003956) | 2.00392942 |
| 92 | Pustule (HP:0200039) | 1.99597461 |
| 93 | Ulnar bowing (HP:0003031) | 1.99562058 |
| 94 | Amyotrophic lateral sclerosis (HP:0007354) | 1.98776515 |
| 95 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98772376 |
| 96 | Basal cell carcinoma (HP:0002671) | 1.98422090 |
| 97 | Abnormality of the fingertips (HP:0001211) | 1.98262487 |
| 98 | Prolonged bleeding time (HP:0003010) | 1.97534741 |
| 99 | Deep palmar crease (HP:0006191) | 1.97445520 |
| 100 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.97201074 |
| 101 | Chest pain (HP:0100749) | 1.96984924 |
| 102 | Gastrointestinal infarctions (HP:0005244) | 1.95995072 |
| 103 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.94369673 |
| 104 | Mediastinal lymphadenopathy (HP:0100721) | 1.94029722 |
| 105 | Radial bowing (HP:0002986) | 1.91924979 |
| 106 | Joint swelling (HP:0001386) | 1.91493542 |
| 107 | Orchitis (HP:0100796) | 1.90996953 |
| 108 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.90900330 |
| 109 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.90900330 |
| 110 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.90900330 |
| 111 | Shallow orbits (HP:0000586) | 1.90450234 |
| 112 | Abnormality of T cells (HP:0002843) | 1.90392175 |
| 113 | Broad metatarsal (HP:0001783) | 1.90166976 |
| 114 | Mucopolysacchariduria (HP:0008155) | 1.89814714 |
| 115 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89814714 |
| 116 | Gangrene (HP:0100758) | 1.89025405 |
| 117 | Thoracic kyphosis (HP:0002942) | 1.88985266 |
| 118 | Abnormality of the motor neurons (HP:0002450) | 1.88764504 |
| 119 | Abnormal neuron morphology (HP:0012757) | 1.88764504 |
| 120 | Vasculitis (HP:0002633) | 1.88184105 |
| 121 | Premature skin wrinkling (HP:0100678) | 1.86703622 |
| 122 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.86378290 |
| 123 | Peritonitis (HP:0002586) | 1.86232541 |
| 124 | Reticulocytopenia (HP:0001896) | 1.86184567 |
| 125 | Spontaneous hematomas (HP:0007420) | 1.86013106 |
| 126 | Emphysema (HP:0002097) | 1.85853775 |
| 127 | Acute hepatic failure (HP:0006554) | 1.85232498 |
| 128 | Ragged-red muscle fibers (HP:0003200) | 1.85066787 |
| 129 | Abnormal platelet function (HP:0011869) | 1.85029998 |
| 130 | Impaired platelet aggregation (HP:0003540) | 1.85029998 |
| 131 | Increased cerebral lipofuscin (HP:0011813) | 1.84914994 |
| 132 | Premature rupture of membranes (HP:0001788) | 1.84628191 |
| 133 | Genu recurvatum (HP:0002816) | 1.84581476 |
| 134 | Increased density of long bones (HP:0006392) | 1.83964354 |
| 135 | Disproportionate tall stature (HP:0001519) | 1.83929671 |
| 136 | Cortical dysplasia (HP:0002539) | 1.83587076 |
| 137 | Epistaxis (HP:0000421) | 1.83332196 |
| 138 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.82117082 |
| 139 | Polycythemia (HP:0001901) | 1.78954582 |
| 140 | Arterial thrombosis (HP:0004420) | 1.78740196 |
| 141 | Gingivitis (HP:0000230) | 1.77552120 |
| 142 | Abnormality of the thoracic spine (HP:0100711) | 1.76711138 |
| 143 | Abnormality of the lower motor neuron (HP:0002366) | 1.76300549 |
| 144 | Systemic lupus erythematosus (HP:0002725) | 1.74670973 |
| 145 | Periodontitis (HP:0000704) | 1.74537160 |
| 146 | Gingival bleeding (HP:0000225) | 1.73126364 |
| 147 | Cervical subluxation (HP:0003308) | 1.72397966 |
| 148 | Abnormality of macrophages (HP:0004311) | 1.72168044 |
| 149 | Selective tooth agenesis (HP:0001592) | 1.71984647 |
| 150 | Striae distensae (HP:0001065) | 1.70267338 |
| 151 | Hypercortisolism (HP:0001578) | 1.69612600 |
| 152 | Hemoptysis (HP:0002105) | 1.67956152 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.70801447 |
| 2 | EEF2K | 3.62957391 |
| 3 | ERN1 | 3.15811020 |
| 4 | MAP3K10 | 3.13811141 |
| 5 | RIPK4 | 2.98692422 |
| 6 | PKN2 | 2.76189417 |
| 7 | MAP4K1 | 2.53736290 |
| 8 | ICK | 2.52935136 |
| 9 | BLK | 2.35960190 |
| 10 | SIK2 | 2.22391805 |
| 11 | ZAP70 | 2.04415857 |
| 12 | SIK3 | 1.90908749 |
| 13 | TBK1 | 1.85302937 |
| 14 | BMX | 1.75738185 |
| 15 | CDK12 | 1.74833591 |
| 16 | BUB1 | 1.65370654 |
| 17 | TYK2 | 1.60895405 |
| 18 | FGFR4 | 1.57690094 |
| 19 | IRAK3 | 1.57470336 |
| 20 | SIK1 | 1.57085732 |
| 21 | FGFR3 | 1.56344750 |
| 22 | IKBKE | 1.50232724 |
| 23 | TESK2 | 1.43786351 |
| 24 | TGFBR2 | 1.42195060 |
| 25 | TAOK1 | 1.39176502 |
| 26 | IRAK4 | 1.33809095 |
| 27 | TTN | 1.31502972 |
| 28 | TLK1 | 1.29888062 |
| 29 | GRK6 | 1.27123215 |
| 30 | NEK2 | 1.25034354 |
| 31 | BTK | 1.25003359 |
| 32 | PAK4 | 1.22577801 |
| 33 | TNK2 | 1.22321099 |
| 34 | LRRK2 | 1.19478740 |
| 35 | BCKDK | 1.17248455 |
| 36 | CDK4 | 1.15955467 |
| 37 | PASK | 1.14646614 |
| 38 | ALK | 1.12416035 |
| 39 | DYRK1B | 1.11534995 |
| 40 | CDC42BPA | 1.11163140 |
| 41 | CSK | 1.10846267 |
| 42 | HCK | 1.08683599 |
| 43 | NME2 | 1.08086793 |
| 44 | MAP3K11 | 1.07798161 |
| 45 | STK10 | 1.05620269 |
| 46 | SYK | 1.04616458 |
| 47 | MAPK12 | 1.03621395 |
| 48 | MAP3K3 | 1.03514072 |
| 49 | KIT | 1.03397301 |
| 50 | MAP3K1 | 1.02489198 |
| 51 | CDK19 | 1.02072517 |
| 52 | MAP2K2 | 1.01670355 |
| 53 | PTK6 | 1.01436547 |
| 54 | MAP3K6 | 0.98501530 |
| 55 | PIM1 | 0.96964401 |
| 56 | CSF1R | 0.96810518 |
| 57 | JAK1 | 0.93908538 |
| 58 | MAP2K6 | 0.93865302 |
| 59 | IKBKB | 0.92652362 |
| 60 | ILK | 0.92267907 |
| 61 | PIM2 | 0.91533480 |
| 62 | UHMK1 | 0.90232358 |
| 63 | FES | 0.89879316 |
| 64 | JAK3 | 0.86330827 |
| 65 | JAK2 | 0.85958100 |
| 66 | CHUK | 0.85800131 |
| 67 | DAPK3 | 0.84897487 |
| 68 | PDGFRA | 0.83612837 |
| 69 | MAPK11 | 0.83529092 |
| 70 | MAP3K14 | 0.79890207 |
| 71 | MARK2 | 0.78252701 |
| 72 | MTOR | 0.78017913 |
| 73 | LCK | 0.76031229 |
| 74 | MAP3K7 | 0.75653217 |
| 75 | SCYL2 | 0.73343251 |
| 76 | FLT3 | 0.73193699 |
| 77 | KDR | 0.73112256 |
| 78 | ADRBK2 | 0.70250427 |
| 79 | RPS6KA4 | 0.70193646 |
| 80 | FGR | 0.69233268 |
| 81 | RPS6KC1 | 0.65894952 |
| 82 | RPS6KL1 | 0.65894952 |
| 83 | PTK2B | 0.65507710 |
| 84 | TEC | 0.64883216 |
| 85 | CDK7 | 0.64368787 |
| 86 | CDK6 | 0.64098148 |
| 87 | MAPK7 | 0.62040282 |
| 88 | PRKCQ | 0.61101671 |
| 89 | DYRK3 | 0.60760150 |
| 90 | MUSK | 0.60258087 |
| 91 | RPS6KB2 | 0.59978146 |
| 92 | RPS6KA6 | 0.59632807 |
| 93 | CAMKK2 | 0.59240010 |
| 94 | EPHB1 | 0.58034699 |
| 95 | MAPKAPK3 | 0.57958213 |
| 96 | FYN | 0.57539293 |
| 97 | EPHA3 | 0.57308388 |
| 98 | RPS6KA1 | 0.56866144 |
| 99 | MAP2K3 | 0.55958747 |
| 100 | PDK1 | 0.55525502 |
| 101 | PRPF4B | 0.54298216 |
| 102 | PRKD2 | 0.53902327 |
| 103 | TYRO3 | 0.53694492 |
| 104 | MAP3K5 | 0.52506039 |
| 105 | CAMKK1 | 0.50869753 |
| 106 | GRK7 | 0.50844049 |
| 107 | TXK | 0.49807080 |
| 108 | PDPK1 | 0.48537027 |
| 109 | ITK | 0.47314799 |
| 110 | TESK1 | 0.46796075 |
| 111 | PDGFRB | 0.46046822 |
| 112 | RPS6KA2 | 0.45033838 |
| 113 | FGFR1 | 0.44626336 |
| 114 | LYN | 0.44178953 |
| 115 | RIPK1 | 0.44086822 |
| 116 | DAPK2 | 0.43169299 |
| 117 | PRKCZ | 0.41834540 |
| 118 | MAP3K13 | 0.41197613 |
| 119 | ARAF | 0.40911700 |
| 120 | MAP2K4 | 0.39807794 |
| 121 | DDR2 | 0.39131028 |
| 122 | MARK3 | 0.38742210 |
| 123 | TAOK3 | 0.38240740 |
| 124 | MAPK15 | 0.37402422 |
| 125 | MATK | 0.37167311 |
| 126 | AKT2 | 0.36886641 |
| 127 | CDK9 | 0.36686663 |
| 128 | TAOK2 | 0.36187316 |
| 129 | MAPKAPK2 | 0.35189649 |
| 130 | HIPK2 | 0.34578081 |
| 131 | BMPR2 | 0.33637639 |
| 132 | MAP2K7 | 0.33304956 |
| 133 | IRAK2 | 0.31405435 |
| 134 | MAPK4 | 0.31301150 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.85746987 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.80544966 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.73089059 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.34221868 |
| 5 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.32152604 |
| 6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.15576287 |
| 7 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 2.05173170 |
| 8 | Sulfur relay system_Homo sapiens_hsa04122 | 1.95812454 |
| 9 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.91492514 |
| 10 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.91103185 |
| 11 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.89888695 |
| 12 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.87364017 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.86298973 |
| 14 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.86281420 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.82036964 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.76101021 |
| 17 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.75937429 |
| 18 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.71231066 |
| 19 | Apoptosis_Homo sapiens_hsa04210 | 1.70423301 |
| 20 | Asthma_Homo sapiens_hsa05310 | 1.63407662 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.61986395 |
| 22 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.60890634 |
| 23 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.53715094 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.52771611 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.50024436 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.47798514 |
| 27 | Shigellosis_Homo sapiens_hsa05131 | 1.46341399 |
| 28 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.45941047 |
| 29 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45217027 |
| 30 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.43659030 |
| 31 | Viral myocarditis_Homo sapiens_hsa05416 | 1.42361588 |
| 32 | Lysine degradation_Homo sapiens_hsa00310 | 1.39571019 |
| 33 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.31953323 |
| 34 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.31438819 |
| 35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.29293872 |
| 36 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.29033045 |
| 37 | Bladder cancer_Homo sapiens_hsa05219 | 1.28672083 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.25590311 |
| 39 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.24731839 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.24426867 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.24225117 |
| 42 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.24120209 |
| 43 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23259282 |
| 44 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.22776140 |
| 45 | Ribosome_Homo sapiens_hsa03010 | 1.22333305 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.21774544 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.21494057 |
| 48 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.16333558 |
| 49 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14318025 |
| 50 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.13605901 |
| 51 | Phagosome_Homo sapiens_hsa04145 | 1.13556208 |
| 52 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.12691154 |
| 53 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12293169 |
| 54 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.09971521 |
| 55 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.09568983 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 1.07012483 |
| 57 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.05959540 |
| 58 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.04788777 |
| 59 | Lysosome_Homo sapiens_hsa04142 | 1.04639504 |
| 60 | Spliceosome_Homo sapiens_hsa03040 | 1.04465960 |
| 61 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.03476850 |
| 62 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.02734134 |
| 63 | Influenza A_Homo sapiens_hsa05164 | 1.01284044 |
| 64 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.00561267 |
| 65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.99870703 |
| 66 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.99281266 |
| 67 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.97356308 |
| 68 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.96062375 |
| 69 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.96050663 |
| 70 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.95135207 |
| 71 | Legionellosis_Homo sapiens_hsa05134 | 0.92411563 |
| 72 | Tuberculosis_Homo sapiens_hsa05152 | 0.90892319 |
| 73 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.90482819 |
| 74 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.89727986 |
| 75 | * Endocytosis_Homo sapiens_hsa04144 | 0.88671769 |
| 76 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.87256207 |
| 77 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.86700383 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.86397656 |
| 79 | Colorectal cancer_Homo sapiens_hsa05210 | 0.85607765 |
| 80 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.85034648 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84986995 |
| 82 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83445182 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.83229562 |
| 84 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.82032121 |
| 85 | Allograft rejection_Homo sapiens_hsa05330 | 0.81022795 |
| 86 | Insulin resistance_Homo sapiens_hsa04931 | 0.80883539 |
| 87 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.79968381 |
| 88 | Platelet activation_Homo sapiens_hsa04611 | 0.79877746 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.79844796 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79074084 |
| 91 | Salmonella infection_Homo sapiens_hsa05132 | 0.78329840 |
| 92 | Endometrial cancer_Homo sapiens_hsa05213 | 0.77361691 |
| 93 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.76326065 |
| 94 | Pertussis_Homo sapiens_hsa05133 | 0.74936058 |
| 95 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.73958099 |
| 96 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.73905474 |
| 97 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73514568 |
| 98 | DNA replication_Homo sapiens_hsa03030 | 0.71405531 |
| 99 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.68825776 |
| 100 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.68332780 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.65777621 |
| 102 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.65494853 |
| 103 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65379444 |
| 104 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.63905504 |
| 105 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.62515745 |
| 106 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.62157072 |
| 107 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62082724 |
| 108 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.62009556 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.61656040 |
| 110 | Focal adhesion_Homo sapiens_hsa04510 | 0.59923773 |
| 111 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.59109196 |
| 112 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58275383 |
| 113 | Glioma_Homo sapiens_hsa05214 | 0.57368959 |
| 114 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.56102282 |
| 115 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54408149 |
| 116 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.53283237 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.51883101 |
| 118 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50057124 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49194670 |
| 120 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.48974930 |
| 121 | Hepatitis C_Homo sapiens_hsa05160 | 0.46431266 |
| 122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45280191 |
| 123 | ABC transporters_Homo sapiens_hsa02010 | 0.45263992 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.45004398 |
| 125 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.44425758 |
| 126 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.44067779 |
| 127 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43654708 |
| 128 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41974572 |
| 129 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.41388237 |
| 130 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.37209642 |
| 131 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36935261 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.32350527 |
| 133 | Galactose metabolism_Homo sapiens_hsa00052 | 0.31953509 |
| 134 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30924418 |
| 135 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28441821 |

